Tag: Aripiprazole lauroxil

According to research, a significant portion of patients with schizophrenia struggle with adherence to daily oral medication regimens, making long-acting injectables (LAIs) an important treatment option. Several LAIs have received FDA approval to help manage schizophrenia symptoms and reduce the risk of relapse.

Aristada (aripiprazole lauroxil) is a long-acting injectable suspension indicated for the treatment of schizophrenia, offering different dosing frequencies to support patient adherence. The administration of this medication requires specific training and must be performed by a healthcare professional, making it crucial to understand the proper procedure for how to administer an Aristada injection safely and effectively.